Recent News

• 09.10.2025 - S-3 - Registration statement under Securities Act of 1933
• 09.10.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 09.08.2025 - Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
• 09.02.2025 - Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
• 08.25.2025 - Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 08.20.2025 - Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
• 08.18.2025 - Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial
• 08.12.2025 - Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology
• 08.08.2025 - Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference
• 08.04.2025 - 4 - Statement of changes in beneficial ownership of securities

Recent Filings

• 09.10.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 09.10.2025 - S-3 Registration statement under Securities Act of 1933
• 08.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.21.2025 - 4 Statement of changes in beneficial ownership of securities